CME Group Inc. (CME) Financials
CME Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 129.8 billion | 103.1 billion |
| 2023-09-30 | 125.6 billion | 97.4 billion |
| 2023-06-30 | 151.3 billion | 123.5 billion |
| 2023-03-31 | 166.0 billion | 138.7 billion |
CME Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 1.0 billion | 24.3 million |
| 2023-09-30 | 836.8 million | 18.9 million |
| 2023-06-30 | 629.9 million | 19.5 million |
| 2023-03-31 | 887.2 million | 20.2 million |
CME Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 833.4 million |
| 2023-09-30 | 750.2 million |
| 2023-06-30 | 777.6 million |
| 2023-03-31 | 883.8 million |
CME Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 3.0 billion | - | - |
| 2023-09-30 | 2.4 billion | - | - |
| 2023-06-30 | 2.0 billion | 3.4 billion | - |
| 2023-03-31 | 1.7 billion | 3.4 billion | - |
CME Shares Outstanding
CME Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 20.8 million | - | 36.1 million | - |
| 2023-09-30 | 19.9 million | 55.6 million | 32.2 million | - |
| 2023-06-30 | 20.5 million | 53.3 million | 37.8 million | - |
| 2023-03-31 | 15.2 million | 51.3 million | 38.3 million | - |
CME Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 1.4 billion | 261.3 million |
| 2023-09-30 | 1.3 billion | 205.5 million |
| 2023-06-30 | 1.4 billion | 205.7 million |
| 2023-03-31 | 1.4 billion | 204.5 million |
CME
List: Contenders
Price: $209.65
Dividend Yield: 0.02%
Forward Dividend Yield: 2.19%
Payout Ratio: 55.29%
Dividend Per Share: 4.60 USD
Earnings Per Share: 8.86 USD
P/E Ratio: 24.65
Exchange: NMS
Sector: Financial Services
Industry: Financial Data & Stock Exchanges
Volume: 3.1 million
Ebitda: 655.4 millionMarket Capitalization: 76.6 billion
Average Dividend Frequency: 4
Years Paying Dividends: 22
DGR3: 30.00%
DGR5: 30.00%
DGR10: 20.84%